Senti Biosciences Stock (NASDAQ:SNTI), Quotes and News Summary

Q: What sector and industry does Senti Biosciences (SNTI) operate in?

Senti Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Senti Biosciences Stock (NASDAQ: SNTI) stock price, news, charts, stock research, profile.

Open	$0.290
Close	$0.308
Volume / Avg.	53.084K / 83.681K
Day Range	0.290 - 0.327
52 Wk Range	0.270 - 1.220
Market Cap	$13.916M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	39
Short Interest	0.7%
Days to Cover	2.09

Recent News

Why Is Blood Cancer Focused Senti Biosciences Stock Trading Higher Today?

Senti Biosciences Inc (NASDAQ: SNTI) received FDA clearance for its Investigational New Drug (IND) application for SENTI-202, an off-the-shelf chimeric antigen receptor natural killer (CAR-NK) cell therapy product candidate designed to selectively target and eliminate CD33 and/or FLT3 expressing hemato

Vandana Singh

Crude Oil Falls Sharply; Datadog Shares Spike Higher

U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining around 1% on Tuesday The Dow traded up 0.21% to 34,166.89 while the NASDAQ rose 1.09% to 13,666.65. The S&P 500 also rose, gaining, 0.41% to 4,383.80.

Lisa Levin

Why Sanmina Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

Gainers PaxMedica, Inc. (NASDAQ: PXMD) shares climbed 173.8% to $8.35. PaxMedica announced the publication of its autism spectrum disorder Phase 2 study results in the Annals of General Psychiatry.

Lisa Levin

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Rating

2.8

Hold

Strong Buy

Buy

Hold

Sell

Strong Sell

About Senti Biosciences Inc.

Sector

Health Care

Industry

Biotechnology

Senti Biosciences Inc is a clinical-stage biotechnology company developing next-generation cell and ...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Senti Biosciences (SNTI) stock?

You can purchase shares of Senti Biosciences (NASDAQ: SNTI) through any online brokerage.

View our list of the best stock brokerages.

Who are Senti Biosciences's (SNTI) competitors?

Other companies in Senti Biosciences’s space includes: Eterna Therapeutics (NASDAQ:ERNA), Immuron (NASDAQ:IMRN), Dominari Holdings (NASDAQ:DOMH), Imunon (NASDAQ:IMNN) and Monopar Therapeutics (NASDAQ:MNPR).

What is the target price for Senti Biosciences (SNTI) stock?

The latest price target for Senti Biosciences (NASDAQ: SNTI) was reported by Chardan Capital on Tuesday, August 15, 2023. The analyst firm set a price target for 6.00 expecting SNTI to rise to within 12 months (a possible 1870.44% upside). 2 analyst firms have reported ratings in the last year.

Current Stock Price for Senti Biosciences (SNTI)?

The stock price for Senti Biosciences (NASDAQ: SNTI) is $0.3045 last updated April 18, 2024 at 4:37 PM EDT.

Does Senti Biosciences (SNTI) pay a dividend?

There are no upcoming dividends for Senti Biosciences.

When is Senti Biosciences (NASDAQ:SNTI) reporting earnings?

Senti Biosciences’s Q1 earnings are confirmed for Tuesday, May 7, 2024.

Is Senti Biosciences (SNTI) going to split?

There is no upcoming split for Senti Biosciences.

What sector and industry does Senti Biosciences (SNTI) operate in?

Senti Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-